Comparable stake leader
PRICE T ROWE ASSOCIATES INC /MD/
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001674632.
Comparable stake leader
PRICE T ROWE ASSOCIATES INC /MD/
Disclosed value leader
PRICE T ROWE ASSOCIATES INC /MD/
Comparable rows
15/50
Latest evidence
11 Nov 2026
Ownership snapshot
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Quick read
15 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| PRICE T ROWE ASSOCIATES INC /MD/ |
13D/G
T. Rowe Price Associates, Inc.
|
17%
Reported 13D/G
· 30 Sep 2026
|
$169,741,981
8,943,061 shares
|
$0 | 30 Sep 2026 |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
13D/G
Company
|
13%
Reported 13D/G
· 31 Mar 2026
|
$133,724,910
7,044,630 shares
|
— | 30 Sep 2026 |
| Zone Healthcare Holdings, LLC |
13D/G
Dapice Joshua J.
|
9.9%
Reported 13D/G
· 30 Sep 2025
|
$85,717,590
4,313,920 shares
|
+$17,618,729 | 30 Sep 2025 |
| Soleus Capital Group, LLC |
13D/G
Levy Guy
|
9.8%
Reported 13D/G
· 31 Mar 2026
|
$38,580,879
4,354,501 shares
|
$0 | 31 Mar 2026 |
| Soleus Capital Master Fund, L.P. |
13D/G
Levy Guy
|
8.7%
Reported 13D/G
· 30 Sep 2026
|
$91,550,616
4,828,619 shares
|
$0 | 30 Sep 2026 |
| MORGAN STANLEY |
13F
13D/G
Company
|
8.6%
Reported 13D/G
· 30 Sep 2025
|
$82,210,844
4,331,446 shares
|
— | 30 Sep 2026 |
| Sands Capital Life Sciences Pulse Fund II, L.P. |
13D/G
|
8.2%
Reported 13D/G
· 30 Jun 2025
|
$48,410,732
3,570,113 shares
|
+$5,636,946 | 30 Jun 2025 |
| Farallon Capital Partners, L.P. |
13D/G
Dapice Joshua J.
|
8.1%
Reported 13D/G
· 31 Mar 2026
|
$31,966,171
3,607,920 shares
|
-$6,839,920 | 31 Mar 2026 |
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Net insider flow leans to selling over the last 12 months. Net value: -$4,634,215.
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 134,720 | $0 | $2,605,011 | -$2,605,011 |
| 3-6 | 0 | 57,223 | $0 | $766,591 | -$766,591 |
| 6-9 | 0 | 353 | $0 | $4,084 | -$4,084 |
| 9-12 | 0 | 42,522 | $0 | $1,258,529 | -$1,258,529 |
Reporting owners
Showing 1-12 of 12 reporting-owner rows connected to Beta Bionics, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Sean Saint | President & CEO, Director | $7,999,577 | -$744,510 | -8.5% | Filing P/S | 03 Sep 2026 |
| Mike Mensinger | Chief Product Officer | $3,844,280 | -$583,769 | -13% | Filing P/S | 27 Oct 2026 |
| Steven Jon Russell | Chief Medical Officer | $3,242,116 | -$163,973 | -4.8% | Filing P/S | 02 Sep 2026 |
| Stephen Feider | Chief Financial Officer | $2,742,162 | -$1,186,512 | -30% | Filing P/S | 11 Nov 2026 |
| Mark Hopman | Chief Commercial Officer | $915,016 | -$1,623,005 | -64% | Filing P/S | 02 Nov 2026 |
| Adam Lezack | Director | $591,679 | -$62,680 | -9.6% | Mixed | 21 May 2026 |
| Christy Jones | Director | $449,972 | -$228,214 | -34% | Filing P/S | 22 Sep 2026 |
| Gerard J. Michel | Director | $335,760 | Mixed | 21 May 2026 | ||
| Danny L. Dearen | Director | $322,734 | Mixed | 21 May 2026 | ||
| Sean Carney | Director | $322,734 | Mixed | 21 May 2026 | ||
| Maria Palasis | Director | $294,557 | -$41,552 | -12% | Mixed | 21 May 2026 |
| Wellington Hadley Harbor Aggregator IV, L.P. | 10%+ Owner | $78,032 | Filing P/S | 31 Jan 2025 |
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Stephen Feider | BBNX | Common Stock | Sale | -5.27% | -$152,681 | $17.21 | -8,874 | 159,378 | 11 Nov 2026 | Direct |
| Stephen Feider | BBNX | Common Stock | Options Exercise | 5.57% | 8,874 | 168,252 | 11 Nov 2026 | Direct | ||
| Stephen Feider | BBNX | Employee Stock Option (right to buy) | Options Exercise | -23% | -8,874 | 29,695 | 11 Nov 2026 | Direct | ||
| Stephen Feider | BBNX | Common Stock | Sale | -0.46% | -$12,649 | $17.00 | -744 | 159,378 | 09 Nov 2026 | Direct |
| Stephen Feider | BBNX | Common Stock | Options Exercise | 0.47% | 744 | 160,122 | 09 Nov 2026 | Direct | ||
| Stephen Feider | BBNX | Employee Stock Option (right to buy) | Options Exercise | -1.89% | -744 | 38,569 | 09 Nov 2026 | Direct | ||
| Stephen Feider | BBNX | Common Stock | Sale | -0.24% | -$6,508 | $17.04 | -382 | 159,378 | 05 Nov 2026 | Direct |
| Stephen Feider | BBNX | Common Stock | Options Exercise | 0.24% | 382 | 159,760 | 05 Nov 2026 | Direct | ||
| Stephen Feider | BBNX | Employee Stock Option (right to buy) | Options Exercise | -0.96% | -382 | 39,313 | 05 Nov 2026 | Direct | ||
| Mark Hopman | BBNX | Common Stock | Sale | -0.68% | -$6,253 | $16.90 | -370 | 54,143 | 02 Nov 2026 | Direct |
| Mike Mensinger | BBNX | Common Stock | Sale | -1.49% | -$58,300 | $22.00 | -2,650 | 174,740 | 27 Oct 2026 | Direct |
| Mark Hopman | BBNX | Common Stock | Sale | -1.48% | -$16,420 | $20.00 | -821 | 54,513 | 26 Oct 2026 | Direct |
| Mark Hopman | BBNX | Common Stock | Sale | -1.38% | -$13,446 | $17.35 | -775 | 55,334 | 14 Oct 2026 | Direct |
| Mark Hopman | BBNX | Common Stock | Sale | -0.66% | -$7,015 | $18.96 | -370 | 56,109 | 01 Oct 2026 | Direct |
| Christy Jones | BBNX | Common Stock | Sale | -24.7% | -$147,890 | $23.00 | -6,430 | 19,564 | 22 Sep 2026 | Direct |
| Mark Hopman | BBNX | Common Stock | Sale | -35.3% | -$619,640 | $20.13 | -30,779 | 56,479 | 16 Sep 2026 | Direct |
| Mike Mensinger | BBNX | Common Stock | Sale | -1.47% | -$58,300 | $22.00 | -2,650 | 177,390 | 16 Sep 2026 | Direct |
| Mark Hopman | BBNX | Common Stock | Sale | -0.89% | -$12,028 | $15.52 | -775 | 86,382 | 14 Sep 2026 | Direct |
| Mark Hopman | BBNX | Common Stock | Sale | -29% | -$664,550 | $18.46 | -35,994 | 88,033 | 09 Sep 2026 | Direct |
| Sean Saint | BBNX | Common Stock | Sale | -1.4% | -$113,259 | $20.08 | -5,641 | 398,429 | 03 Sep 2026 | Direct |
| Mark Hopman | BBNX | Common Stock | Sale | -4.12% | -$101,815 | $19.11 | -5,327 | 124,027 | 02 Sep 2026 | Direct |
| Steven Jon Russell | BBNX | Common Stock | Sale | -2.43% | -$80,676 | $19.11 | -4,221 | 169,628 | 02 Sep 2026 | Direct |
| Mike Mensinger | BBNX | Common Stock | Sale | -2.37% | -$83,620 | $19.11 | -4,375 | 180,040 | 02 Sep 2026 | Direct |
| Stephen Feider | BBNX | Common Stock | Sale | -4.02% | -$127,580 | $19.11 | -6,675 | 159,378 | 02 Sep 2026 | Direct |
| Sean Saint | BBNX | Common Stock | Sale | -4.01% | -$322,381 | $19.11 | -16,867 | 404,070 | 02 Sep 2026 | Direct |
| Stephen Feider | BBNX | Common Stock | Sale | -2.86% | -$83,381 | $17.03 | -4,896 | 166,053 | 29 Jun 2026 | Direct |
| Stephen Feider | BBNX | Common Stock | Options Exercise | 2.95% | 4,896 | 170,949 | 29 Jun 2026 | Direct | ||
| Stephen Feider | BBNX | Employee Stock Option (right to buy) | Options Exercise | -11% | -4,896 | 39,695 | 29 Jun 2026 | Direct | ||
| Stephen Feider | BBNX | Common Stock | Sale | -2.98% | -$87,006 | $17.05 | -5,104 | 166,053 | 26 Jun 2026 | Direct |
| Stephen Feider | BBNX | Common Stock | Options Exercise | 3.07% | 5,104 | 171,157 | 26 Jun 2026 | Direct | ||
| Stephen Feider | BBNX | Employee Stock Option (right to buy) | Options Exercise | -10.3% | -5,104 | 44,591 | 26 Jun 2026 | Direct | ||
| Mark Hopman | BBNX | Common Stock | Sale | -0.96% | -$18,880 | $15.01 | -1,258 | 129,354 | 24 Jun 2026 | Direct |
| Christy Jones | BBNX | Common Stock | Sale | -5.13% | -$21,090 | $15.00 | -1,406 | 25,994 | 24 Jun 2026 | Direct |
| Mark Hopman | BBNX | Common Stock | Sale | -0.21% | -$3,385 | $12.31 | -275 | 130,612 | 04 Jun 2026 | Direct |
| Christy Jones | BBNX | Common Stock | Sale | -9.3% | -$39,354 | $14.00 | -2,811 | 27,400 | 04 Jun 2026 | Direct |
| Mike Mensinger | BBNX | Common Stock | Sale | -2.32% | -$55,194 | $12.61 | -4,378 | 184,415 | 02 Jun 2026 | Direct |
| Mark Hopman | BBNX | Common Stock | Sale | -3.91% | -$67,183 | $12.61 | -5,329 | 130,887 | 02 Jun 2026 | Direct |
| Steven Jon Russell | BBNX | Common Stock | Sale | -2.37% | -$53,227 | $12.61 | -4,222 | 173,849 | 02 Jun 2026 | Direct |
| Stephen Feider | BBNX | Common Stock | Sale | -3.87% | -$84,165 | $12.61 | -6,676 | 166,053 | 02 Jun 2026 | Direct |
| Sean Saint | BBNX | Common Stock | Sale | -3.85% | -$212,707 | $12.61 | -16,872 | 420,937 | 02 Jun 2026 | Direct |
| Adam Lezack | BBNX | Comon Stock | Sale | -3.51% | -$11,188 | $11.21 | -998 | 27,399 | 22 May 2026 | Direct |
| Gerard J. Michel | BBNX | Common Stock | Award | 102.5% | 16,965 | 33,509 | 21 May 2026 | Direct | ||
| Christy Jones | BBNX | Common Stock | Award | 128.1% | 16,965 | 30,211 | 21 May 2026 | Direct | ||
| Christy Jones | BBNX | Common Stock | Sale | -13.1% | -$19,880 | $9.95 | -1,998 | 13,246 | 21 May 2026 | Direct |
| Maria Palasis | BBNX | Common Stock | Award | 136.5% | 16,965 | 29,397 | 21 May 2026 | Direct | ||
| Danny L. Dearen | BBNX | Common Stock | Award | 111.3% | 16,965 | 32,209 | 21 May 2026 | Direct | ||
| Sean Carney | BBNX | Common Stock | Award | 111.3% | 16,965 | 32,209 | 21 May 2026 | Direct | ||
| Adam Lezack | BBNX | Common Stock | Award | 148.4% | 16,965 | 28,397 | 21 May 2026 | Direct | ||
| Adam Lezack | BBNX | Common Stock | Sale | -8.04% | -$9,950 | $9.95 | -1,000 | 11,432 | 21 May 2026 | Direct |
| Mark Hopman | BBNX | Common Stock | Sale | -0.25% | -$4,084 | $11.57 | -353 | 139,133 | 04 Mar 2026 | Direct |